Loading insider details...
Latest Form 4 (Nov 6, 2026): Exercise/Conversion of 1,500 REGN shares, $1.09M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,500 | $1.09M |
| Feb 11, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,000 | $492.0K |
| Dec 9, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 2,064 | n/a |
| Nov 10, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 431 | $280.8K |
| Dec 18, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 298 | $217.8K |
| Dec 10, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 907 | n/a |
| Aug 7, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 487 | $181.4K |